P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note
PharmaResearch Co Ltd
/
Income Statement
/
EPS (Diluted)

PharmaResearch Co Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
EPS (Diluted)
₩8.6k
CAGR 3-Years
27%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
EPS (Diluted)
₩1.6k
CAGR 3-Years
-28%
CAGR 5-Years
-2%
CAGR 10-Years
6%
SK Bioscience Co Ltd
KRX:302440
EPS (Diluted)
₩289
CAGR 3-Years
-18%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
EPS (Diluted)
-₩1.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
EPS (Diluted)
₩9.9k
CAGR 3-Years
26%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
EPS (Diluted)
-₩24
CAGR 3-Years
53%
CAGR 5-Years
36%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P
What is Intrinsic Value?

See Also

What is PharmaResearch Co Ltd's EPS (Diluted)?
EPS (Diluted)
8.6k KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's EPS (Diluted) amounts to 8.6k KRW.

What is PharmaResearch Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
36%

Over the last year, the EPS (Diluted) growth was 64%. The average annual EPS (Diluted) growth rates for PharmaResearch Co Ltd have been 27% over the past three years , 36% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.